Loading EVH total return...
Loading summary...

About EVH Dividend Returns

Evolent Health, Inc. (EVH) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of EVH over the past year?

Evolent Health, Inc. (EVH) delivered a total return of -63.00% over the past year when dividends are reinvested. The price-only return was -63.00%, meaning dividends contributed an additional 0.00 percentage points to total returns.

Q2How much would $10,000 invested in EVH be worth today?

A $10,000 investment in Evolent Health, Inc. one year ago would be worth $3,700 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $3,700. Dividend reinvestment added $0 to the portfolio value.

Q3Does EVH pay dividends?

Yes, Evolent Health, Inc. (EVH) pays dividends. In the last year, EVH paid approximately $0.10 per share in dividends (2.54% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did EVH beat the S&P 500?

No, Evolent Health, Inc. (EVH) underperformed the S&P 500 by 94.32 percentage points over the past year. EVH delivered a total return of -63.00%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed EVH by 94.32pp during this period.

Q5What is EVH's worst drawdown?

Evolent Health, Inc. (EVH) experienced a maximum drawdown of -81.59% over the past year, declining from its peak on 2025-07-03 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is EVH's long-term total return over 10, 20, or 30 years?

Here are Evolent Health, Inc. (EVH)'s long-term returns with dividends reinvested. Over 10 years, the total return is -67.1% (-10.5% CAGR) — $10,000 would have grown to $3,290. Over 20 years: -79.7% total return (-7.7% CAGR) — $10,000 → $2,031. Over 30 years: -79.7% total return (-5.2% CAGR) — $10,000 → $2,031. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was EVH's best and worst year?

Evolent Health, Inc.'s best calendar year was 2021 with a total return of 70.4%. Its worst year was 2024 with a total return of -66.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 136.6 percentage points.

💰

Find the Best Dividend Stocks

Screen for dividend stocks with the highest total returns (including DRIP).

View Dividend Stocks →

Compare Similar Stocks

Deep Dive into EVH